The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis

Nephron - Experimental Nephrology

Volumn 102, Issue 1, 2006, Pages

  Monkawa, Toshiaki ^a,d   Pippin, Jeffrey ^a   Yo, Yoshikage ^c   Kopp, Jeffrey B ^c   Alpers, Charles E ^b   Shankland, Stuart J ^a,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d KEIO UNIVERSITY   (Japan)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Cyclin kinase inhibitor; Glomerulonephritis; p21

Indexed keywords

ALBUMIN; ANTISERUM; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL SWELLING; CELL VACUOLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA SYNTHESIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LYSIS; MESANGIUM CELL; MOUSE; NECROSIS; NICK END LABELING; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PODOCYTE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHEEP; SILVER STAINING; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; WILD TYPE;

ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; CELL PROLIFERATION; COMPLEMENT C3; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FIBROSIS; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PROTEINURIA; SHEEP; STAINING AND LABELING;

EID: 32844466937     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088311     Document Type: Article

References (24)

1. Johnson RJ: The glomerular response to injury: progression or resolution? Kidney Int 1994;45:1769-1782.
2. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92:2952-2962.
3. Pippin JW, Qu Q, Meijer L, Shankland SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine: a novel cyclin-dependent kinase antagonist. J Clin Invest 1997;100:2512-2520.
4. Savill J: Apoptosis: A mechanism for regulation of the cell complement of inflamed glomeruli. Kidney Int 1992;41:607-612.
5. Hattori T, Shindo S, Kawamura H: Apoptosis and expression of Bax protein and Fas antigen in glomeruli of a remnant-kidney model. Nephron 1998;79:186-191.
6. Roberts JM, Koff A, Polyak K, Firpo E, Collins S, Ohtsubo M, Massague J: Cyclins, CDKs, and cyclin kinase inhibitors. Cold Spring Harbor Symp Quant Biol 1994;59:31-38.
7. Shankland SJ, Wolf G: Cell cycle proteins and the kidney: role in proliferation, growth and apoptosis (Invited Review). Am J Physiol 2000;278:F515-F529.
8. Weiss RH, Randour CJ: The permissive effect on p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells. Cell Signal 2000;12:413-418.
9. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE: Differential expression of CDK-inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000;58:674-683.
10. Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 1997;52:404-413.
11. Kim Y-G, Pippin JW, Johnson RJ, Alpers CE, Couser WG, Shankland SJ: The cyclin kinase inhibitor p21Cip1/WAF1 limits visceral glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 1999;55:2349-2361.
12. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 1996;50:1230-1239.
13. Yo Y, Braun MC, Barisoni L, Mobaraki H, Lu H, Shrivastav S, Owens J, JB: K. Anti-mouse mesangial cell serum induces acute glomerulonephropathy in mice. Nephron Exp Nephrol 2003;93:92-106.
14. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ: Radiation-induced cell cycle arrest comprimised by p21-deficiency. Nature 1995;377:552-557.
15. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ: The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 1998;4:575-580.
16. CIP1/WAF1 limits interstitial but not tubular cell proliferation in tubulointerstitial injury induced by ureteric obstruction. Am J Physiol 1999;277:F948-F956.
17. WAF/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int 1999;56:1691-1699.
18. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangial cell: a glomerular fibroblast? JASN 1992;2:S190-S197.
19. Monkawa T, Wolf G, Hiromura K, Shankland SJ: TGF-beta mediates its anti-proliferative and hypertrophic effects through separate cell cycle pathways: Role of cyclin-dependent kinase-inhibitors p21 and p27 (abstract). J Am Soc Nephrol 2001;12:617A.
20. Savill J: Apoptosis in resolution of inflammation. J Leukoc Biol 1997;61:375-380.
21. Gartel AL, Tyner AL: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002;8:639-649.
22. Megyesi J, Safirstein RL, Price PM: Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998;101:777-782.
23. Megyesi J, Udvarhelyi N, Safirstein RL, Price PM: The p53-independent activation of transcription of p21WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol 1996;271:F1211-F1216.
24. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, Martinez AC: The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med 2000;6:171-176.